Safety and Efficacy of Litramine in Overweight and Obese Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions

OverweightObesityWeight Loss

Interventions

DEVICE

Litramine

2 tablets 3 times daily (oral consumption, 30 minutes after meal)

DEVICE

Placebo

2 tablets 3 times daily (oral consumption, 30 minutes after meal)

Trial Locations (1)

Barbara Grube, Berlin